Previously, he was the Director of Scientific Leadership and Clinical Research at Stryker EMEA in Switzerland and Director, Clinical Research Worldwide at Howmedica, a division of Pfizer Inc. During his tenure, he designed and implemented both pre- and post-marketing clinical studies on Hips, Knees, Trauma, Spine and Orthobiologics. He established an Innovation Board comprising Key Opinion Leaders (KOLs) in EMEA to evaluate innovative technologies in Orthopaedics and Spine.
At both Howmedica and Stryker he conducted due diligence on a number of potential acquisition targets. Over the last 25 years, he has developed strong working relationships with leading Orthopaedic, Spine and Neurosurgeons as well as medical industry leaders worldwide.
Murali holds an MBA from Columbia University, PhD in Biomedical Engineering from University of Kentucky.